Datexim
The company develops AI-powered digital cytology software, specifically the CytoProcessor system, for cervical cancer screening. The platform automatically analyzes digitized slides to identify and classify abnormal cells, supporting clinical workflows in pathology laboratories. It integrates with existing scanners and laboratory information systems to assist pathologists and cytotechnologists in diagnostic efficiency.
Healthtech
Artificial Intelligence
Digital Pathology
Diagnostics
Funding summary
- Total raised
- €1.0M
- Funding rounds
- 1
Investors in Datexim
Investors on record for Datexim. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Datexim?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors